CONTINUE TO SITE ➞

Don't miss tomorrow's biopharma industry news

Let BioPharma Dive's free newsletter keep you informed, straight from your inbox.

Daily Dive M-F

Commercialization Weekly Every Wednesday

Gene Therapy Weekly Every Thursday

Emerging Biotech Weekly Every Tuesday

By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Deep Dive
Library
Events
Press Releases

Pharma
Biotech
FDA
Clinical Trials
Deals
Drug Pricing
Gene Therapy

What We're Reading: Page 363

Industry reads hand-picked by our editors

Aug 03, 2015

Seeking Alpha
Pfizer inks deal for generic Copaxone from Dutch firm
Reuters
Brain training app could help people with schizophrenia
San Francisco Business Times
UC system's research generated 86 startups in just 2014

Jul 31, 2015

Reuters
Healthcare deals lift July to 7th busiest M&A month on record
Bloomberg
U.S. said to drop 12-year lock-up on biologics data in TPP talks
Reuters
World Medical Association to look into future president after Reuters story

Jul 30, 2015

The Street
MannKind to use mix of discounted stock, more debt to settle $100M loan
Reuters
Teva MS flagship Copaxone has a strong Q2
Bloomberg
Valeant tells Congress a very different tax tale than investors

Jul 29, 2015

Bloomberg
Glaxo earnings beat estimates on AIDS drugs, cost reductions
Reuters
Sanofi diabetes combo hits goal in late-stage trial
Bloomberg
Pfizer quits OTC Lipitor program after trial fails

Jul 28, 2015

WSJ
Pfizer boosts earnings outlook, pins future sales growth on new treatments
FierceBiotech
Esperion still hoping it can take on the PCSK9 giants
USA Today
Merck sales fall, but earnings beat expectations

Jul 27, 2015

Reuters
AZ sells rare cancer drug to Sanofi for up to $300 million
Bloomberg
These superhumans are real and their DNA could be worth billions
Reuters
New heart drugs come in significantly more expensive than expected

Jul 24, 2015

Reuters
AZ chasing Avastin biosim with Japanese group
Healthcare Dive
Anthem moves to buy Cigna in massive $54.2B mega-merger deal
Reuters
Novartis melanoma drug combo wins EU green light

Previous Next

Get the free newsletter

Subscribe to BioPharma Dive for top news, trends & analysis

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.

Library resources

Webinar - on demand
Navigating the Impact of Claims Data Volatility on Biopharma Custom content for McKesson Compile
Infographic
Cutting Through the Chaos of Safety Letter Distribution Custom content for WCG
Playbook
How To Make the Most of Your Life Science Webinars Custom content for Cvent

View all

Company Announcements

View all | Post a press release

Events

View all | Promote an event

Industry Intel

Revolutionizing Next Generation Gene Therapies with On-Demand Large DNA Construct Synthesis and Novel, Designable Delivery Vehicles Webinar - on demand • Provided by Ansa Biotechnologies
Enhance Drug Discovery with CADD and Agentic AI on Rescale, AWS, and NVIDIA Webinar - on demand • Provided by Amazon Web Services (AWS), NVIDIA, and Rescale
AI-Powered Biomarker Discovery: From Screening to Translational Insights Webinar - on demand • Provided by Danaher

Explore

About
Editorial Team
Contact Us
Newsletter
Purchase Licensing Rights
Press Releases
What We're Reading

Reach our audience

Advertising
Post a press release
Promote an event

Related Publications

Healthcare Dive
MedTech Dive

Industry Dive is an Informa TechTarget business.

This website is owned and operated by Informa TechTarget, part of a global network that informs, influences and connects the world's technology buyers and sellers. All copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget, Inc.'s registered office is 275 Grove St. Newton, MA 02466.

Home
- Pharma
- Biotech
- FDA
- Clinical Trials
- Deals
- Drug Pricing
- Gene Therapy
Deep Dive
Library
Events
Press Releases

Get BioPharma Dive in your inbox

The free newsletter covering the top industry headlines

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.